We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Randomized crossover trial evaluates albuminuria reduction with dapagliflozin and eplerenone in chronic kidney disease, suggesting therapeutic potential for combination therapy.
European Union Clinical Trials Register, EU 2017-004641-25.
No takes yet. Share an insight, caveat, or question.
Provenzano et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: